VOYA INVESTMENT MANAGEMENT LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,994,653
+150.7%
75,641
+63.5%
0.00%
+200.0%
Q2 2023$795,724
-65.0%
46,263
-66.2%
0.00%
-66.7%
Q1 2023$2,270,514
+616.6%
136,943
+229.4%
0.00%
Q4 2022$316,824
-23.3%
41,5780.0%0.00%
-100.0%
Q3 2022$413,285
+9.3%
41,5780.0%0.00%0.0%
Q2 2022$378,000
-10.4%
41,5780.0%0.00%0.0%
Q1 2022$422,000
-39.2%
41,5780.0%0.00%0.0%
Q4 2021$694,000
-64.8%
41,578
-1.1%
0.00%
-75.0%
Q3 2021$1,971,000
-23.7%
42,060
-0.8%
0.00%
-20.0%
Q2 2021$2,583,000
+1.6%
42,379
+2.7%
0.01%0.0%
Q1 2021$2,543,000
+12.9%
41,278
+30.3%
0.01%0.0%
Q4 2020$2,253,000
+139.7%
31,688
+26.5%
0.01%
+150.0%
Q3 2020$940,000
+12.0%
25,042
-2.6%
0.00%0.0%
Q2 2020$839,000
-21.9%
25,717
-30.6%
0.00%
-33.3%
Q1 2020$1,074,000
+182.6%
37,038
+241.7%
0.00%
+200.0%
Q4 2019$380,00010,8390.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders